REAL

The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments

Kohajda, Zsófia and Morvay, Nikolett and Jost, Norbert László and Nagy, Norbert and Geramipour, Amir Mohammad and Horváth, András and Varga, Richárd Sándor and Hornyik, Tibor and Corici, Claudia and Acsai, Károly and Horváth, Balázs and Prorok, János and Ördög, Balázs and Déri, Szilvia and Tóth, Dániel and Tóth, András and Baczkó, István and Leprán, István and Nánási, Péter Pál and Papp, Gyula and Varró, András and Virág, László (2016) The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments. PLOS ONE, 11 (11). ISSN 1932-6203

[img]
Preview
Text
KohajdaPLoSOne_ORM10962_2016.pdf

Download (3MB) | Preview

Abstract

BACKGROUND: In this study the effects of a new, highly selective sodium-calcium exchanger (NCX) inhibitor, ORM-10962 were investigated on cardiac NCX current, Ca2+ transients, cell shortening and in experimental arrhythmias. The level of selectivity of the novel inhibitor on several major transmembrane ion currents (L-type Ca2+ current, major repolarizing K+ currents, late Na+ current, Na+/K+ pump current) was also determined. METHODS: Ion currents in single dog ventricular cells (cardiac myocytes; CM), and action potentials in dog cardiac multicellular preparations were recorded utilizing the whole-cell patch clamp and standard microelectrode techniques, respectively. Ca2+ transients and cell shortening were measured in fluorescent dye loaded isolated dog myocytes. Antiarrhythmic effects of ORM-10962 were studied in anesthetized ouabain (10 mug/kg/min i.v.) pretreated guinea pigs and in ischemia-reperfusion models (I/R) of anesthetized coronary artery occluded rats and Langendorff perfused guinea pigs hearts. RESULTS: ORM-10962 significantly reduced the inward/outward NCX currents with estimated EC50 values of 55/67 nM, respectively. The compound, even at a high concentration of 1 muM, did not modify significantly the magnitude of ICaL in CMs, neither had any apparent influence on the inward rectifier, transient outward, the rapid and slow components of the delayed rectifier potassium currents, the late and peak sodium and Na+/K+ pump currents. NCX inhibition exerted moderate positive inotropic effect under normal condition, negative inotropy when reverse, and further positive inotropic effect when forward mode was facilitated. In dog Purkinje fibres 1 muM ORM-10962 decreased the amplitude of digoxin induced delayed afterdepolarizations (DADs). Pre-treatment with 0.3 mg/kg ORM-10962 (i.v.) 10 min before starting ouabain infusion significantly delayed the development and recurrence of ventricular extrasystoles (by about 50%) or ventricular tachycardia (by about 30%) in anesthetized guinea pigs. On the contrary, ORM-10962 pre-treatment had no apparent influence on the time of onset or the severity of I/R induced arrhythmias in anesthetized rats and in Langendorff perfused guinea-pig hearts. CONCLUSIONS: The present study provides strong evidence for a high efficacy and selectivity of the NCX-inhibitory effect of ORM-10962. Selective NCX inhibition can exert positive as well as negative inotropic effect depending on the actual operation mode of NCX. Selective NCX blockade may contribute to the prevention of DAD based arrhythmogenesis, in vivo, however, its effect on I/R induced arrhythmias is still uncertain.

Item Type: Article
Additional Information: Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary MTA-SZTE Research Group of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary Department of Pathophysiology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Department of Dental Physiology and Pharmacology, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary Orion Pharma, Espoo, Finland Cited By :10 Export Date: 17 September 2019 CODEN: POLNC Chemicals/CAS: adenosine triphosphatase (potassium sodium); calcium, 7440-70-2, 14092-94-5; Anti-Arrhythmia Agents; Calcium; Sodium-Calcium Exchanger Tradenames: orm 10962 Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary MTA-SZTE Research Group of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary Department of Pathophysiology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Department of Dental Physiology and Pharmacology, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary Orion Pharma, Espoo, Finland Cited By :10 Export Date: 23 September 2019 CODEN: POLNC Chemicals/CAS: adenosine triphosphatase (potassium sodium); calcium, 7440-70-2, 14092-94-5; Anti-Arrhythmia Agents; Calcium; Sodium-Calcium Exchanger Tradenames: orm 10962 Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary MTA-SZTE Research Group of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary Department of Pathophysiology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Department of Dental Physiology and Pharmacology, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary Orion Pharma, Espoo, Finland Cited By :10 Export Date: 24 September 2019 CODEN: POLNC Chemicals/CAS: adenosine triphosphatase (potassium sodium); calcium, 7440-70-2, 14092-94-5; Anti-Arrhythmia Agents; Calcium; Sodium-Calcium Exchanger Tradenames: orm 10962 Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary MTA-SZTE Research Group of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary Department of Pathophysiology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Department of Dental Physiology and Pharmacology, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary Orion Pharma, Espoo, Finland Cited By :12 Export Date: 27 January 2020 CODEN: POLNC Chemicals/CAS: adenosine triphosphatase (potassium sodium); calcium, 7440-70-2, 14092-94-5; Anti-Arrhythmia Agents; Calcium; Sodium-Calcium Exchanger Tradenames: orm 10962 Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary MTA-SZTE Research Group of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary Department of Pathophysiology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Department of Dental Physiology and Pharmacology, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary Orion Pharma, Espoo, Finland Cited By :12 Export Date: 12 February 2020 CODEN: POLNC Chemicals/CAS: adenosine triphosphatase (potassium sodium); calcium, 7440-70-2, 14092-94-5; Anti-Arrhythmia Agents; Calcium; Sodium-Calcium Exchanger Tradenames: orm 10962 Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary MTA-SZTE Research Group of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary Department of Pathophysiology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Department of Dental Physiology and Pharmacology, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary Orion Pharma, Espoo, Finland Cited By :12 Export Date: 13 February 2020 CODEN: POLNC Chemicals/CAS: adenosine triphosphatase (potassium sodium); calcium, 7440-70-2, 14092-94-5; Anti-Arrhythmia Agents; Calcium; Sodium-Calcium Exchanger Tradenames: orm 10962 Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary MTA-SZTE Research Group of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary Department of Pathophysiology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Department of Dental Physiology and Pharmacology, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary Orion Pharma, Espoo, Finland Cited By :12 Export Date: 14 February 2020 CODEN: POLNC Chemicals/CAS: adenosine triphosphatase (potassium sodium); calcium, 7440-70-2, 14092-94-5; Anti-Arrhythmia Agents; Calcium; Sodium-Calcium Exchanger Tradenames: orm 10962 Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary MTA-SZTE Research Group of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary Department of Pathophysiology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Department of Dental Physiology and Pharmacology, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary Orion Pharma, Espoo, Finland Cited By :14 Export Date: 25 February 2020 CODEN: POLNC Chemicals/CAS: adenosine triphosphatase (potassium sodium); calcium, 7440-70-2, 14092-94-5; Anti-Arrhythmia Agents; Calcium; Sodium-Calcium Exchanger Tradenames: orm 10962 Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary MTA-SZTE Research Group of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary Department of Pathophysiology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Department of Dental Physiology and Pharmacology, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary Orion Pharma, Espoo, Finland Cited By :16 Export Date: 10 July 2020 CODEN: POLNC Chemicals/CAS: adenosine triphosphatase (potassium sodium); calcium, 7440-70-2, 14092-94-5; Anti-Arrhythmia Agents; Calcium; Sodium-Calcium Exchanger Tradenames: orm 10962
Subjects: R Medicine / orvostudomány > RC Internal medicine / belgyógyászat
SWORD Depositor: MTMT SWORD
Depositing User: MTMT SWORD
Date Deposited: 07 Jan 2021 15:09
Last Modified: 07 Jan 2021 15:09
URI: http://real.mtak.hu/id/eprint/119297

Actions (login required)

Edit Item Edit Item